United States · FDA National Drug Code directory
Doxepin Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-2408_8e5a9620-a6e9-402a-aa93-da77ff5c8d98
- Product NDC
- 71335-2408
- Form
- CAPSULE
- Composition / generic term
- Doxepin Hydrochloride
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210501
- Source listing expiry
- 20261231
Source-listed ingredients
- DOXEPIN HYDROCHLORIDE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 CAPSULE in 1 BOTTLE (71335-2408-1) · 71335-2408-1
- 30 CAPSULE in 1 BOTTLE (71335-2408-2) · 71335-2408-2
- 90 CAPSULE in 1 BOTTLE (71335-2408-3) · 71335-2408-3
- 120 CAPSULE in 1 BOTTLE (71335-2408-4) · 71335-2408-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →